H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 429,954. Minnesota Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Minneapolis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Minneapolis storefront.
For Wound Care Specialists in Minneapolis, MN for clinics & physicians. Advanced wound care products for w… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 15.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. wound care specialists inventory is national; utilization is J6-local.
National For Wound Care Specialists notes (how the product actually works)J6 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Minneapolis is 7.4% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J6 articles mapped. 9.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 28.6%; arthritis is 15.2%. That is place-level BRFSS modeling, not a clinic census and not a Minneapolis trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow National Government Services (NGS) CTP articles. Mixing those codes is a billing error.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. National Government Services (NGS) writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
If you operate in Minnesota and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Minneapolis tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Minneapolis, MN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Minneapolis is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Minneapolis — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Minnesota Part B wound biologics follow this contractor (siblings: IL, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Minneapolis. Useful for joint-program math; still needs a diagnosis and privileging.
No Minneapolis storefront. Joe Bradley is an active practice owner. wound care specialists stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.